Altor BioScience Corporation is a biopharmaceutical company engaged in the discovery, development and commercialization of high-value, targeted immuno-therapeutic agents for the treatment of cancer, viral infections and autoimmune disease. The company has developed proprietary technology for producing soluble T-cell receptor molecules which specifically recognize novel targets on cancerous or virally infected cells not accessible to therapeutic antibodies or any other means currently available.
Contact Altor BioScience Corporation:
